Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as her successor at Biocon, launching a gradual leadership transition. The founder, who built the biotech company from a garage into a global player, will remain involved while Claire—positioned as a more science-driven leader—takes on increasing responsibility during the handover period.
Biocon founder Kiran Mazumdar-Shaw has reportedly named her niece, Claire Mazumdar, as the company’s successor. Claire, founder and CEO of Bicara Therapeutics, brings advanced qualifications and prior industry experience. The announcement also comes amid broader structural and leadership changes across Biocon group firms as it pushes biosimilars and deeper artificial intelligence integration.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
